Short Summary
The case was transferred from the Intellectual Property Appellate Board (IPAB) to the High Court at Calcutta following the enactment of the Tribunals Reform Act, 2021. The court directed the Commercial Appellate Division to issue notices to both parties and file a report before listing the matter in March 2023.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in JW Pharmaceutical Corporation (Formerly Choongwae Pharma Corporation) vs Controller General of Patent and Designs and Anr is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
V.Lakshminarayanasamy & Suguna LakshminarayanasamyvsSiva Bhaskaren & The Deputy Registrar, Trademark Registry, Chennai
The Madras High Court dismissed a petition seeking the removal or cancellation of Trademark Registration No. 1191299, which was registered in Siva Bhaskaren's name for goods like pressure cookers and fans. The court noted that the trademark's validity expired on April 10, 2023, as no renewal request had been filed within the ten-year period. Consequently, the petition seeking rectification became infructuous, leading to its closure.
MSN LABORATORIES PRIVATE LIMITEDvsTHE CONTROLLER OF PATENTS, BOUDHIK SAMPADA BHAVAN, DWARKA, SECTOR-32, PLOT 14 NEW DELHI-400037; BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
The plaintiff (MSN Laboratories) filed a petition seeking the revocation of Indian Patent No. IN 243301. The defendants argued that the petition was time-barred as it was filed more than three years after the patent grant date. The court dismissed the applications, holding that the limitation period for challenging a patent is not necessarily from the date of grant but when the right to sue accrues, and affirming its territorial jurisdiction.
Incyte Holdings Corporation & Ors.vsAeon Formulations Pvt. Ltd.
The Plaintiffs, owners/licensees of Indian Patent No. 269841 covering Ruxolitinib compounds (used in treating Mye), filed a suit against Aeon Formulations Pvt. Ltd. seeking permanent injunction against infringement. The court passed an order granting various exemptions and appointing Local Commissioners to inspect the Defendant's premises, seize samples of the infringing drug, and gather evidence.
Nokia Technologies OyvsAssistant Controller Of Patents And Designs
Nokia Technologies Oy filed an appeal under Section 117A(2) of the Patents Act, 1970, challenging the rejection of its patent application no. 201917042060 by the Assistant Controller of Patents and Designs. The appellant also sought condonation for a delay of 53 days in filing the appeal.
V.K.R.VenkatesanvsV.Mahendran
V.K.R.Venkatesan filed a civil suit against V.Mahendran alleging multiple infringements related to the 'VKR SIVAJI BRAND' mark and associated artistic works used on rice products. The plaintiff sought permanent injunctions against trademark infringement, copyright violation, and passing off. However, before any judgment was passed on the merits of the case, the learned counsel for the plaintiff filed an endorsement requesting withdrawal of the suit.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.